Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management

Phase 2 Unknown 150 enrolled University of Baghdad

RandomizedParallel-groupOpen-labelTreatment

Summary

Assessment of the Effectiveness of Niclosamide as Add on Therapy to the Standard of care Measures in COVID-19 Management in a randomized controlled clinical trial

Timeline

Start: 2021-01-03
Primary completion: 2021-12-03
Completion: 2021-12-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Niclosamide	Unknown	1 g	Oral

Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management

Summary

Timeline

Drugs

Indications